Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · PUEBLO, CO · NPI 1245295013
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 594 | 154 |
| Atorvastatin Calcium | Atorvastatin Calcium | 488 | 132 |
| Amlodipine Besylate | Amlodipine Besylate | 375 | 98 |
| Lisinopril | Lisinopril | 333 | 100 |
| Losartan Potassium | Losartan Potassium | 271 | 77 |
| Omeprazole | Omeprazole | 221 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 211 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 209 | 62 |
| Metformin Hcl Er | Metformin Hcl | 198 | 62 |
| Metoprolol Succinate | Metoprolol Succinate | 179 | 47 |
| Gabapentin | Gabapentin | 167 | 40 |
| Trazodone Hcl | Trazodone Hcl | 162 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 139 | 37 |
| Simvastatin | Simvastatin | 139 | 38 |
| Metformin Hcl | Metformin Hcl | 135 | 37 |
| Tramadol Hcl | Tramadol Hcl | 130 | 25 |
| Allopurinol | Allopurinol | 123 | 34 |
| Meloxicam | Meloxicam | 123 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 119 | 28 |
| Sertraline Hcl | Sertraline Hcl | 109 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 105 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 103 | 28 |
| Furosemide | Furosemide | 95 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 87 | 29 |
| Alprazolam | Alprazolam | 83 | 16 |
| Atenolol | Atenolol | 83 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 78 | 28 |
| Bupropion Xl | Bupropion Hcl | 78 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 27 |
| Glipizide Er | Glipizide | 77 | 23 |
| Mirtazapine | Mirtazapine | 73 | 19 |
| Potassium Chloride | Potassium Chloride | 73 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 71 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 12 |
| Donepezil Hcl | Donepezil Hcl | 62 | 18 |
| Eliquis | Apixaban | 60 | 12 |
| Finasteride | Finasteride | 60 | 17 |
| Celecoxib | Celecoxib | 57 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 17 |
| Alendronate Sodium | Alendronate Sodium | 56 | 17 |
| Spironolactone | Spironolactone | 54 | 15 |
| Lovastatin | Lovastatin | 53 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | 18 |
| Carvedilol | Carvedilol | 50 | 14 |
| Naproxen | Naproxen | 49 | 13 |
| Clonazepam | Clonazepam | 48 | suppressed |
| Ozempic | Semaglutide | 47 | 15 |
| Prednisone | Prednisone | 47 | 20 |
| Valsartan | Valsartan | 46 | 13 |
| Farxiga | Dapagliflozin Propanediol | 45 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 44 | 13 |
| Warfarin Sodium | Warfarin Sodium | 44 | 14 |
| Methocarbamol | Methocarbamol | 43 | 15 |
| Acyclovir | Acyclovir | 42 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 39 | suppressed |
| Primidone | Primidone | 38 | suppressed |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Ibuprofen | Ibuprofen | 37 | suppressed |
| Pregabalin | Pregabalin | 37 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Glimepiride | Glimepiride | 36 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | 12 |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 30 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Irbesartan | Irbesartan | 29 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 28 | 11 |
| Jardiance | Empagliflozin | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 26 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 19 |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 13 |
| Topiramate | Topiramate | 23 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 15 |
| Famotidine | Famotidine | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 14 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Temazepam | Temazepam | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Qulipta | Atogepant | 16 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Cefdinir | Cefdinir | 14 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Repatha Sureclick | Evolocumab | 14 | suppressed |
| Trulicity | Dulaglutide | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Praluent Pen | Alirocumab | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error